The global tuberculosis burden remains substantial, with more than 10 million people newly
ill per year. Nevertheless, tuberculosis incidence has slowly declined over the past decade …

The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Background Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is
still limited. The aim of this study was to describe the features of the TB/COVID-19 co …

SARS-CoV-2 variants that escape neutralization and potentially affect vaccine efficacy have
emerged. T cell responses play a role in protection from reinfection and severe disease, but …

Summary The Johnson and Johnson Ad26. COV2. S single-dose vaccine represents an
attractive option for coronavirus disease 2019 (COVID-19) vaccination in countries with …

Latent tuberculosis infection was the term traditionally used to indicate tuberculosis (TB)
infection. This term was used to define “a state of persistent immune response to stimulation …

This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …

Knowledge of aging biology needs to be expanded due to the continuously growing number
of elderly people worldwide. Aging induces changes that affect all systems of the body. The …

Few studies from Africa have described the clinical impact of co-infections on SARS-CoV-2
infection. Here, we investigate the presentation and outcome of SARS-CoV-2 infection in an …

Exceptional efforts have been undertaken to shed light into the biology of adaptive immune
responses to SARS-CoV-2. T cells occupy a central role in adaptive immunity to mediate …